Palacky University in Olomouc | Czech Republic
Author Profiles
Scopus
Orcid ID
Early Academic Pursuits
Prof. Dr. Radim Vrzal began his academic journey with a Master’s degree in Biochemistry from the Institute of Chemical Technology in Prague (1998–2003). His academic excellence and research aptitude led him to pursue a Ph.D. in cotutelle between Palacký University, Olomouc, and INSERM, Montpellier, France, where he investigated biochemical mechanisms under expert international guidance. This early exposure to collaborative research set the foundation for his future contributions in molecular biology, pharmacology, and toxicology.
Professional Endeavors
He commenced his professional career as an Assistant Professor at the Institute of Medical Chemistry and Biochemistry, Palacký University, in 2006. His teaching and research responsibilities later expanded at the Department of Cell Biology and Genetics, where he has served as an Associate Professor since 2011. Over the years, he has demonstrated excellence in pedagogy, supervising more than 40 students across bachelor’s, master’s, and Ph.D. levels, while consistently engaging in advanced teaching in hematology, human genetics, and toxicology.
Contributions and Research Focus
Prof. Vrzal’s research spans a wide spectrum of molecular and cellular biology, with a special emphasis on ligand-activated nuclear receptors, drug metabolism, cytotoxicity, and cellular signaling. His investigations into the biological activity of natural and synthetic compounds, post-translational modifications of nuclear receptors, and applications of human intestinal organoids mark his innovative approach to biomedical research. His ongoing work in prostate cancer and anticancer therapeutics highlights the translational value of his research.
Impact and Influence
With 99 publications indexed in WoS, over 1,600 citations (excluding self-citations), and an H-index of 25, Prof. Vrzal has established a solid academic presence. His work has significantly contributed to understanding receptor-mediated mechanisms and their pharmacological implications, influencing both academic discourse and applied therapeutic research. As a grant holder and collaborator, he has led and co-led several national and international projects, including studies on MAP kinases, CYP3A4 enzyme regulation, and synthetic tryptamine derivatives for cancer treatment.
Academic Citations
His research is widely cited, reflecting the global relevance of his work. The citation record underscores his contributions to advancing pharmacology and toxicology, where his insights have informed subsequent studies on drug metabolism and receptor signaling. This recognition also highlights his influence on shaping research directions in biochemical and biomedical sciences.
Legacy and Future Contributions
Prof. Vrzal’s legacy lies in his dual commitment to advancing scientific research and nurturing the next generation of scholars. His supervision of numerous students and his long-standing dedication to teaching ensure knowledge transfer and academic continuity. Looking forward, his ongoing projects on anticancer therapeutics and cellular models hold promise for impactful discoveries in medicine and pharmacotherapy.
Conclusion
Prof. Dr. Radim Vrzal exemplifies the qualities of a dedicated researcher, mentor, and innovator. His academic trajectory, impactful research contributions, and sustained influence in molecular and biomedical sciences position him as a deserving candidate for recognition. His ability to bridge fundamental science with applied therapeutic research ensures that his future work will continue to make meaningful contributions to both academia and society.
Notable Publications
“Skin-targeted AhR activation by microbial and synthetic indoles: Insights from the AhaRaCaT reporter cell"
- Author: Radim Vrzal; Aneta Grycová; Aneta Vrzalová
- Journal: Toxicology Letters
- Year: 2025
"Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation"
- Author: Aneta Vrzalova; Radim Vrzal
- Journal: Biochimie
- Year: 2025
"Modulation of aryl hydrocarbon receptor activity by halogenated indoles"
- Author: Aneta Vrzalová; Radim Vrzal; Petr Nádvorník; Marek Šebela; Zdeněk Dvořák
- Journal: Bioorganic and Medicinal Chemistry
- Year: 2024
"Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)"
- Author: Radim Vrzal; Adéla Marcalíková; Kristýna Krasulová; Lenka Zemánková; Zdeněk Dvořák
- Journal: International Journal of Molecular Sciences
- Year: 2023
"Monoterpenoid aryl hydrocarbon receptor allosteric antagonists protect against ultraviolet skin damage in female mice"
- Author: Karolína Ondrová; Iveta Zůvalová; Barbora Vyhlídalová; Kristýna Krasulová; Eva Miková; Radim Vrzal; Petr Nádvorník; Martina Kopečná; David Kopečný; Marek Šebela et al.
- Journal: Nature Communications
- Year: 2021